Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001663585 | SCV001880486 | pathogenic | not provided | 2021-03-06 | criteria provided, single submitter | clinical testing | This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual, including a de novo case, with clinical features associated with this gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant will result in premature termination of the protein due to abnormal RNA splicing (PMID:15248095). |
Gene |
RCV001663585 | SCV003842785 | likely pathogenic | not provided | 2022-09-16 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect on splicing with skipping of exon 11 in a patient with hereditary spastic paraplegia (Svenson et al., 2004); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15248095, 31157359, 27334366) |
Mayo Clinic Laboratories, |
RCV001663585 | SCV005413214 | likely pathogenic | not provided | 2023-12-06 | criteria provided, single submitter | clinical testing | PM2_moderate, PM6, PS3 |